ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.

Bo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.